Takeda Pharmaceutical Company Limited
TKPHF News Today: Stay Updated with the Latest Takeda Pharmaceutical Company Limited News in Real Time
Find TKPHF news now at Meyka AI. Stay informed with the latest Takeda Pharmaceutical Company Limited stocks updates, including price news, market analysis, and expert insights.

5595.T Stock Bounces 6.96% on Oversold Conditions, Apr 16
5595.T stock rallies 6.96% as oversold bounce emerges. Institute for Q-shu Pioneers trades at ¥1,736 on JPX with strong intraday recovery.

SAP.DE Stock Rises 2.1% in Pre-Market Trading on April 16
SAP.DE stock gains 2.1% to €146.54 in pre-market session. Enterprise software leader shows mixed technical signals ahead of earnings announcement.

43Q.SI Stock Surges 1.68% on Volume Spike to 50,500 Shares in Pre-Market
43Q.SI stock jumps 1.68% with volume spike to 50,500 shares. Advancer Global Limited trades at S$0.121 on Singapore Exchange.

BRP Inc. (DOO.TO) Plunges 35% on Tariff Shock, Guidance Withdrawn
DOO.TO stock crashes 35.4% as BRP withdraws guidance citing U.S. metal tariffs. Powersports maker faces headwinds on TSX.

BIT.AX stock plunges 33% on 16 Apr 2026 amid biotech selloff
Biotron Limited (BIT.AX) crashes 33% to A$0.002 on ASX. Healthcare biotech stock faces heavy losses with weak fundamentals and negative cash flow.

LRHC Stock Drops 7.28% on April 15 as Orlando Acquisition Closes
LRHC stock fell 7.28% to $0.4126 on April 15, 2026. La Rosa Holdings completes Orlando brokerage acquisition for $3.3M revenue unit.

TATAELXSI.NS stock gains 2.93% on 16 Apr 2026 amid AI momentum
TATAELXSI.NS stock rises 2.93% to INR 4540.6 on NSE. Tata Elxsi Limited shows strong technical signals with B+ grade from Meyka AI.

MPGPF: Citigroup Maintains Buy Rating, Cuts Price Target April 2026
Citigroup maintains Buy rating on PageGroup (MPGPF) but cuts price target to 300 GBp from 440 GBp on April 15, 2026.

ASM.AS Stock Hits €753.60 on April 16, 2026 Ahead of Earnings
ASM International NV (ASM.AS) trades at €753.60 with 0.11% gain in pre-market. Earnings announcement April 21. Meyka rates B+.